Blog Details

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

FDA Takes Action on Bulk Pure Powdered Caffeine Products

Author

Michael Chen

Senior Web Developer
Agency continues to warn consumers about the dangers of using pure powdered caffeine. The U.S. Food and Drug Administration is taking action today to help prevent additional deaths from the use of pure powdered caffeine, potentially dangerous products that have already resulted in the known deaths of two teenagers. The agency issued warning letters to five distributors of pure powdered caffeine because these products are dangerous and present a significant or unreasonable risk of illness or injury to consumers. The difference between a safe amount and a toxic dose of caffeine in these pure powdered products is very small. Furthermore, safe quantities of these products can be nearly impossible to measure accurately with common kitchen measuring tools. Volume measures, such as teaspoons, are not precise enough to calculate how many milligrams of caffeine are in the serving size. Pre-existing conditions can intensify the effects of caffeine and make the product more dangerous for these individuals. Following the deaths of two young men in good health in 2014, the FDA issued Consumer Advice alerting consumers to the dangers of pure powdered caffeine. One teaspoon of pure powdered caffeine is equivalent to the amount of caffeine in about 28 cups of regular coffee. While consumers of caffeinated products such as coffee, tea, and soda may be aware of caffeine’s less serious effects – such as nervousness and tremors – they may not be aware that these pure powdered caffeine products are much more potent and can cause serious health effects, including rapid or dangerously erratic heartbeat, seizures and death. Vomiting, diarrhea, stupor and disorientation are also symptoms of caffeine toxicity. The FDA will continue to aggressively monitor the marketplace for pure powdered caffeine products and take action as appropriate. If violations exist, the FDA can pursue enforcement action, such as seizure of the product or an injunction to prevent the firm from continuing to manufacture or market the product. Source: fda.gov/Food/NewsEvents/ConstituentUpdates/UCM460097

Related Topics

Sarah Anderson

Senior Tech Writer & Developer Advocate
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium. Passionate about creating content that bridges the gap between developers and end-users.

Discussion (8)

Proin iaculis purus consequat sem cure digni ssim donec porttitora entum suscipit rhoncus. Accusantium quam, ultricies eget id, aliquam eget nibh et. Maecen aliquam, risus at semper.

Quisque ut nisi. Donec mi odio, faucibus at, scelerisque quis, convallis in, nisi. Suspendisse non nisl sit amet velit hendrerit rutrum. Ut leo. Ut a nisl id ante tempus hendrerit.

Cras ultricies mi eu turpis hendrerit fringilla. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae.

Nam commodo suscipit quam. Vestibulum ullamcorper mauris at ligula. Fusce fermentum odio nec arcu.

Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim.

Share Your Thoughts

Your email address will not be published. Required fields are marked *